28 Jul 2022
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
On Monday, China's drug regulator (NMPA) conditionally approved a domestically made HIV drug for treating COVID-19 patients.
Some context: The drug, Azvudine, produced by Zhengzhou-based Genuine Biotech, was originally approved for treating HIV-1 infections in July 2021.
Monday's approval mak...
April 16, 2024
Policymakers want the financial system to channel more cash into low-carbon development. The latest: On April 10, several regulators – including the central bank (PBoC), macro planner (NDRC), and securities regulator (CSRC) – issued guidance on increasing financial support for green… Read More »
April 16, 2024
China’s economy grew strongly in the first quarter of 2024. According to data released by the stats bureau (NBS) on Monday: Real GDP grew 5.3% in Q1 2024, up from 5.2% in the previous quarter On a seasonally adjusted quarter-on-quarter… Read More »
April 15, 2024
China and North Korea have lots to talk about. On Saturday, Zhao Leji, chairman of the legislature (NPCSC) and China’s third-ranked official, met with North Korean Supreme Leader Kim Jong-un. ICMYI: On Thursday, Zhao talked up cooperation with his North… Read More »